The global market for Non-invasive DNA Prenatal Testing was valued at US$ 5836 million in the year 2024 and is projected to reach a revised size of US$ 12760 million by 2031, growing at a CAGR of 12.0% during the forecast period.

Non-invasive DNA Prenatal Testing Market

Non-invasive prenatal DNA testing is a new generation of prenatal testing technology that uses next-generation high-throughput sequencing to detect fetal chromosomal abnormalities.

North American market for Non-invasive DNA Prenatal Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Non-invasive DNA Prenatal Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Non-invasive DNA Prenatal Testing in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Non-invasive DNA Prenatal Testing include Illumina, Roche, Natera, Thermo Fisher Scientific, F. Hoffman-La Roche, Pacific Biosciences Of California, Perkinelmer, LifeCodexx, Agilent Technologies, Labcorp, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Non-invasive DNA Prenatal Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-invasive DNA Prenatal Testing.

The Non-invasive DNA Prenatal Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-invasive DNA Prenatal Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-invasive DNA Prenatal Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-invasive DNA Prenatal Testing Market Report

Report Metric	Details
Report Name	Non-invasive DNA Prenatal Testing Market
Accounted market size in year	US$ 5836 million
Forecasted market size in 2031	US$ 12760 million
CAGR	12.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Equipment Consumables
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Illumina, Roche, Natera, Thermo Fisher Scientific, F. Hoffman-La Roche, Pacific Biosciences Of California, Perkinelmer, LifeCodexx, Agilent Technologies, Labcorp, Mutiplicon, Premaitha Health, Beijing BGI, Berry Genomics, Darui Biological
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-invasive DNA Prenatal Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Non-invasive DNA Prenatal Testing Market growing?

Ans: The Non-invasive DNA Prenatal Testing Market witnessing a CAGR of 12.0% during the forecast period 2025-2031.

What is the Non-invasive DNA Prenatal Testing Market size in 2031?

Ans: The Non-invasive DNA Prenatal Testing Market size in 2031 will be US$ 12760 million.

Who are the main players in the Non-invasive DNA Prenatal Testing Market report?

Ans: The main players in the Non-invasive DNA Prenatal Testing Market are Illumina, Roche, Natera, Thermo Fisher Scientific, F. Hoffman-La Roche, Pacific Biosciences Of California, Perkinelmer, LifeCodexx, Agilent Technologies, Labcorp, Mutiplicon, Premaitha Health, Beijing BGI, Berry Genomics, Darui Biological

What are the Application segmentation covered in the Non-invasive DNA Prenatal Testing Market report?

Ans: The Applications covered in the Non-invasive DNA Prenatal Testing Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Non-invasive DNA Prenatal Testing Market report?

Ans: The Types covered in the Non-invasive DNA Prenatal Testing Market report are Equipment, Consumables

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-invasive DNA Prenatal Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Equipment

1.2.3 Consumables

1.3 Market by Application

1.3.1 Global Non-invasive DNA Prenatal Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-invasive DNA Prenatal Testing Market Perspective (2020-2031)

2.2 Global Non-invasive DNA Prenatal Testing Growth Trends by Region

2.2.1 Global Non-invasive DNA Prenatal Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Non-invasive DNA Prenatal Testing Historic Market Size by Region (2020-2025)

2.2.3 Non-invasive DNA Prenatal Testing Forecasted Market Size by Region (2026-2031)

2.3 Non-invasive DNA Prenatal Testing Market Dynamics

2.3.1 Non-invasive DNA Prenatal Testing Industry Trends

2.3.2 Non-invasive DNA Prenatal Testing Market Drivers

2.3.3 Non-invasive DNA Prenatal Testing Market Challenges

2.3.4 Non-invasive DNA Prenatal Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-invasive DNA Prenatal Testing Players by Revenue

3.1.1 Global Top Non-invasive DNA Prenatal Testing Players by Revenue (2020-2025)

3.1.2 Global Non-invasive DNA Prenatal Testing Revenue Market Share by Players (2020-2025)

3.2 Global Non-invasive DNA Prenatal Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Non-invasive DNA Prenatal Testing Revenue

3.4 Global Non-invasive DNA Prenatal Testing Market Concentration Ratio

3.4.1 Global Non-invasive DNA Prenatal Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-invasive DNA Prenatal Testing Revenue in 2024

3.5 Global Key Players of Non-invasive DNA Prenatal Testing Head office and Area Served

3.6 Global Key Players of Non-invasive DNA Prenatal Testing, Product and Application

3.7 Global Key Players of Non-invasive DNA Prenatal Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-invasive DNA Prenatal Testing Breakdown Data by Type

4.1 Global Non-invasive DNA Prenatal Testing Historic Market Size by Type (2020-2025)

4.2 Global Non-invasive DNA Prenatal Testing Forecasted Market Size by Type (2026-2031)

5 Non-invasive DNA Prenatal Testing Breakdown Data by Application

5.1 Global Non-invasive DNA Prenatal Testing Historic Market Size by Application (2020-2025)

5.2 Global Non-invasive DNA Prenatal Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Non-invasive DNA Prenatal Testing Market Size (2020-2031)

6.2 North America Non-invasive DNA Prenatal Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Non-invasive DNA Prenatal Testing Market Size by Country (2020-2025)

6.4 North America Non-invasive DNA Prenatal Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-invasive DNA Prenatal Testing Market Size (2020-2031)

7.2 Europe Non-invasive DNA Prenatal Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Non-invasive DNA Prenatal Testing Market Size by Country (2020-2025)

7.4 Europe Non-invasive DNA Prenatal Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-invasive DNA Prenatal Testing Market Size (2020-2031)

8.2 Asia-Pacific Non-invasive DNA Prenatal Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Non-invasive DNA Prenatal Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Non-invasive DNA Prenatal Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-invasive DNA Prenatal Testing Market Size (2020-2031)

9.2 Latin America Non-invasive DNA Prenatal Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Non-invasive DNA Prenatal Testing Market Size by Country (2020-2025)

9.4 Latin America Non-invasive DNA Prenatal Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size (2020-2031)

10.2 Middle East & Africa Non-invasive DNA Prenatal Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Illumina

11.1.1 Illumina Company Details

11.1.2 Illumina Business Overview

11.1.3 Illumina Non-invasive DNA Prenatal Testing Introduction

11.1.4 Illumina Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025)

11.1.5 Illumina Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Non-invasive DNA Prenatal Testing Introduction

11.2.4 Roche Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025)

11.2.5 Roche Recent Development

11.3 Natera

11.3.1 Natera Company Details

11.3.2 Natera Business Overview

11.3.3 Natera Non-invasive DNA Prenatal Testing Introduction

11.3.4 Natera Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025)

11.3.5 Natera Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Details

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Introduction

11.4.4 Thermo Fisher Scientific Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 F. Hoffman-La Roche

11.5.1 F. Hoffman-La Roche Company Details

11.5.2 F. Hoffman-La Roche Business Overview

11.5.3 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Introduction

11.5.4 F. Hoffman-La Roche Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025)

11.5.5 F. Hoffman-La Roche Recent Development

11.6 Pacific Biosciences Of California

11.6.1 Pacific Biosciences Of California Company Details

11.6.2 Pacific Biosciences Of California Business Overview

11.6.3 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Introduction

11.6.4 Pacific Biosciences Of California Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025)

11.6.5 Pacific Biosciences Of California Recent Development

11.7 Perkinelmer

11.7.1 Perkinelmer Company Details

11.7.2 Perkinelmer Business Overview

11.7.3 Perkinelmer Non-invasive DNA Prenatal Testing Introduction

11.7.4 Perkinelmer Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025)

11.7.5 Perkinelmer Recent Development

11.8 LifeCodexx

11.8.1 LifeCodexx Company Details

11.8.2 LifeCodexx Business Overview

11.8.3 LifeCodexx Non-invasive DNA Prenatal Testing Introduction

11.8.4 LifeCodexx Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025)

11.8.5 LifeCodexx Recent Development

11.9 Agilent Technologies

11.9.1 Agilent Technologies Company Details

11.9.2 Agilent Technologies Business Overview

11.9.3 Agilent Technologies Non-invasive DNA Prenatal Testing Introduction

11.9.4 Agilent Technologies Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025)

11.9.5 Agilent Technologies Recent Development

11.10 Labcorp

11.10.1 Labcorp Company Details

11.10.2 Labcorp Business Overview

11.10.3 Labcorp Non-invasive DNA Prenatal Testing Introduction

11.10.4 Labcorp Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025)

11.10.5 Labcorp Recent Development

11.11 Mutiplicon

11.11.1 Mutiplicon Company Details

11.11.2 Mutiplicon Business Overview

11.11.3 Mutiplicon Non-invasive DNA Prenatal Testing Introduction

11.11.4 Mutiplicon Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025)

11.11.5 Mutiplicon Recent Development

11.12 Premaitha Health

11.12.1 Premaitha Health Company Details

11.12.2 Premaitha Health Business Overview

11.12.3 Premaitha Health Non-invasive DNA Prenatal Testing Introduction

11.12.4 Premaitha Health Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025)

11.12.5 Premaitha Health Recent Development

11.13 Beijing BGI

11.13.1 Beijing BGI Company Details

11.13.2 Beijing BGI Business Overview

11.13.3 Beijing BGI Non-invasive DNA Prenatal Testing Introduction

11.13.4 Beijing BGI Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025)

11.13.5 Beijing BGI Recent Development

11.14 Berry Genomics

11.14.1 Berry Genomics Company Details

11.14.2 Berry Genomics Business Overview

11.14.3 Berry Genomics Non-invasive DNA Prenatal Testing Introduction

11.14.4 Berry Genomics Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025)

11.14.5 Berry Genomics Recent Development

11.15 Darui Biological

11.15.1 Darui Biological Company Details

11.15.2 Darui Biological Business Overview

11.15.3 Darui Biological Non-invasive DNA Prenatal Testing Introduction

11.15.4 Darui Biological Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025)

11.15.5 Darui Biological Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pacific Biosciences of California

List of Tables

Table 1. Global Non-invasive DNA Prenatal Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Equipment

Table 3. Key Players of Consumables

Table 4. Global Non-invasive DNA Prenatal Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Non-invasive DNA Prenatal Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Non-invasive DNA Prenatal Testing Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Non-invasive DNA Prenatal Testing Market Share by Region (2020-2025)

Table 8. Global Non-invasive DNA Prenatal Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Non-invasive DNA Prenatal Testing Market Share by Region (2026-2031)

Table 10. Non-invasive DNA Prenatal Testing Market Trends

Table 11. Non-invasive DNA Prenatal Testing Market Drivers

Table 12. Non-invasive DNA Prenatal Testing Market Challenges

Table 13. Non-invasive DNA Prenatal Testing Market Restraints

Table 14. Global Non-invasive DNA Prenatal Testing Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Non-invasive DNA Prenatal Testing Market Share by Players (2020-2025)

Table 16. Global Top Non-invasive DNA Prenatal Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive DNA Prenatal Testing as of 2024)

Table 17. Ranking of Global Top Non-invasive DNA Prenatal Testing Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Non-invasive DNA Prenatal Testing Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Non-invasive DNA Prenatal Testing, Headquarters and Area Served

Table 20. Global Key Players of Non-invasive DNA Prenatal Testing, Product and Application

Table 21. Global Key Players of Non-invasive DNA Prenatal Testing, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Non-invasive DNA Prenatal Testing Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Type (2020-2025)

Table 25. Global Non-invasive DNA Prenatal Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Type (2026-2031)

Table 27. Global Non-invasive DNA Prenatal Testing Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Application (2020-2025)

Table 29. Global Non-invasive DNA Prenatal Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Application (2026-2031)

Table 31. North America Non-invasive DNA Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Non-invasive DNA Prenatal Testing Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Non-invasive DNA Prenatal Testing Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Non-invasive DNA Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Non-invasive DNA Prenatal Testing Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Non-invasive DNA Prenatal Testing Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Non-invasive DNA Prenatal Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Non-invasive DNA Prenatal Testing Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Non-invasive DNA Prenatal Testing Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Non-invasive DNA Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Non-invasive DNA Prenatal Testing Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Non-invasive DNA Prenatal Testing Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Country (2026-2031) & (US$ Million)

Table 46. Illumina Company Details

Table 47. Illumina Business Overview

Table 48. Illumina Non-invasive DNA Prenatal Testing Product

Table 49. Illumina Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025) & (US$ Million)

Table 50. Illumina Recent Development

Table 51. Roche Company Details

Table 52. Roche Business Overview

Table 53. Roche Non-invasive DNA Prenatal Testing Product

Table 54. Roche Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025) & (US$ Million)

Table 55. Roche Recent Development

Table 56. Natera Company Details

Table 57. Natera Business Overview

Table 58. Natera Non-invasive DNA Prenatal Testing Product

Table 59. Natera Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025) & (US$ Million)

Table 60. Natera Recent Development

Table 61. Thermo Fisher Scientific Company Details

Table 62. Thermo Fisher Scientific Business Overview

Table 63. Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Product

Table 64. Thermo Fisher Scientific Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025) & (US$ Million)

Table 65. Thermo Fisher Scientific Recent Development

Table 66. F. Hoffman-La Roche Company Details

Table 67. F. Hoffman-La Roche Business Overview

Table 68. F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Product

Table 69. F. Hoffman-La Roche Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025) & (US$ Million)

Table 70. F. Hoffman-La Roche Recent Development

Table 71. Pacific Biosciences Of California Company Details

Table 72. Pacific Biosciences Of California Business Overview

Table 73. Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Product

Table 74. Pacific Biosciences Of California Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025) & (US$ Million)

Table 75. Pacific Biosciences Of California Recent Development

Table 76. Perkinelmer Company Details

Table 77. Perkinelmer Business Overview

Table 78. Perkinelmer Non-invasive DNA Prenatal Testing Product

Table 79. Perkinelmer Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025) & (US$ Million)

Table 80. Perkinelmer Recent Development

Table 81. LifeCodexx Company Details

Table 82. LifeCodexx Business Overview

Table 83. LifeCodexx Non-invasive DNA Prenatal Testing Product

Table 84. LifeCodexx Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025) & (US$ Million)

Table 85. LifeCodexx Recent Development

Table 86. Agilent Technologies Company Details

Table 87. Agilent Technologies Business Overview

Table 88. Agilent Technologies Non-invasive DNA Prenatal Testing Product

Table 89. Agilent Technologies Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025) & (US$ Million)

Table 90. Agilent Technologies Recent Development

Table 91. Labcorp Company Details

Table 92. Labcorp Business Overview

Table 93. Labcorp Non-invasive DNA Prenatal Testing Product

Table 94. Labcorp Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025) & (US$ Million)

Table 95. Labcorp Recent Development

Table 96. Mutiplicon Company Details

Table 97. Mutiplicon Business Overview

Table 98. Mutiplicon Non-invasive DNA Prenatal Testing Product

Table 99. Mutiplicon Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025) & (US$ Million)

Table 100. Mutiplicon Recent Development

Table 101. Premaitha Health Company Details

Table 102. Premaitha Health Business Overview

Table 103. Premaitha Health Non-invasive DNA Prenatal Testing Product

Table 104. Premaitha Health Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025) & (US$ Million)

Table 105. Premaitha Health Recent Development

Table 106. Beijing BGI Company Details

Table 107. Beijing BGI Business Overview

Table 108. Beijing BGI Non-invasive DNA Prenatal Testing Product

Table 109. Beijing BGI Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025) & (US$ Million)

Table 110. Beijing BGI Recent Development

Table 111. Berry Genomics Company Details

Table 112. Berry Genomics Business Overview

Table 113. Berry Genomics Non-invasive DNA Prenatal Testing Product

Table 114. Berry Genomics Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025) & (US$ Million)

Table 115. Berry Genomics Recent Development

Table 116. Darui Biological Company Details

Table 117. Darui Biological Business Overview

Table 118. Darui Biological Non-invasive DNA Prenatal Testing Product

Table 119. Darui Biological Revenue in Non-invasive DNA Prenatal Testing Business (2020-2025) & (US$ Million)

Table 120. Darui Biological Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Non-invasive DNA Prenatal Testing Picture

Figure 2. Global Non-invasive DNA Prenatal Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Non-invasive DNA Prenatal Testing Market Share by Type: 2024 VS 2031

Figure 4. Equipment Features

Figure 5. Consumables Features

Figure 6. Global Non-invasive DNA Prenatal Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Non-invasive DNA Prenatal Testing Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Other Case Studies

Figure 11. Non-invasive DNA Prenatal Testing Report Years Considered

Figure 12. Global Non-invasive DNA Prenatal Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Non-invasive DNA Prenatal Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Non-invasive DNA Prenatal Testing Market Share by Region: 2024 VS 2031

Figure 15. Global Non-invasive DNA Prenatal Testing Market Share by Players in 2024

Figure 16. Global Top Non-invasive DNA Prenatal Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive DNA Prenatal Testing as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Non-invasive DNA Prenatal Testing Revenue in 2024

Figure 18. North America Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Non-invasive DNA Prenatal Testing Market Share by Country (2020-2031)

Figure 20. United States Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Non-invasive DNA Prenatal Testing Market Share by Country (2020-2031)

Figure 24. Germany Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Non-invasive DNA Prenatal Testing Market Share by Region (2020-2031)

Figure 32. China Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Non-invasive DNA Prenatal Testing Market Share by Country (2020-2031)

Figure 40. Mexico Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Non-invasive DNA Prenatal Testing Market Share by Country (2020-2031)

Figure 44. Turkey Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Non-invasive DNA Prenatal Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Illumina Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2020-2025)

Figure 48. Roche Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2020-2025)

Figure 49. Natera Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2020-2025)

Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2020-2025)

Figure 51. F. Hoffman-La Roche Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2020-2025)

Figure 52. Pacific Biosciences Of California Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2020-2025)

Figure 53. Perkinelmer Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2020-2025)

Figure 54. LifeCodexx Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2020-2025)

Figure 55. Agilent Technologies Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2020-2025)

Figure 56. Labcorp Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2020-2025)

Figure 57. Mutiplicon Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2020-2025)

Figure 58. Premaitha Health Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2020-2025)

Figure 59. Beijing BGI Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2020-2025)

Figure 60. Berry Genomics Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2020-2025)

Figure 61. Darui Biological Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Non-invasive DNA Prenatal Testing Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-15M15093

Global Non-invasive DNA Prenatal Testing Market Research Report 2025

FEATURED COMPANIES

Non-invasive DNA Prenatal Testing Market Size

Non-invasive DNA Prenatal Testing Market

Scope of Non-invasive DNA Prenatal Testing Market Report

Chapter Outline

FAQ for this report

How fast is Non-invasive DNA Prenatal Testing Market growing?

What is the Non-invasive DNA Prenatal Testing Market size in 2031?

Who are the main players in the Non-invasive DNA Prenatal Testing Market report?

What are the Application segmentation covered in the Non-invasive DNA Prenatal Testing Market report?

What are the Type segmentation covered in the Non-invasive DNA Prenatal Testing Market report?

FEATURED COMPANIES

Global Online Salvage Auctions Market Research Report 2023

Single User, Electronic (PDF)

Global Webtoons Market Insights and Forecast to 2028

Single User, Electronic (PDF)

Online Advertising Market

Single User, Electronic (PDF)